Market revenue in 2021 | USD 1.3 billion |
Market revenue in 2030 | USD 2.0 billion |
Growth rate | 5.5% (CAGR from 2021 to 2030) |
Largest segment | Anti-hypertensive |
Fastest growing segment | Hormones |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD billion |
Market segmentation | Alkylating Agents, Antimetabolites, Hormones, Anti-hypertensive, Lipid Lowering drugs, Anti-depressants, Anti-psychotics, Anti-epileptics |
Key market players worldwide | Teva Pharmaceutical Industries Ltd, Lupin, Sanofi SA, Sun Pharmaceutical Industries, Dr. Reddy’s Laboratories, GlaxoSmithKline, Pfizer Inc, Apotex Inc., Viatris Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to branded generics market will help companies and investors design strategic landscapes.
Anti-hypertensive was the largest segment with a revenue share of 15.38% in 2021. Horizon Databook has segmented the Argentina branded generics market based on alkylating agents, antimetabolites, hormones, anti-hypertensive, lipid lowering drugs, anti-depressants, anti-psychotics, anti-epileptics covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing prevalence of chronic diseases and rising government expenditure in the healthcare sector of the country are anticipated to drive the generic pharmaceuticals market. An article suggests that around USD 414.2 million, USD 233 million, and USD 139.8 million were invested in universal health care, accident & emergency, and solidarity redistribution fund, respectively, in 2019.
The population lacks proper healthcare coverage, and over 36% of the population does not have formal healthcare coverage & is dependent the on public healthcare system. All these factors create an opportunity for branded generic players to fulfill the high demand for low-cost drugs and treatment.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina branded generics market , including forecasts for subscribers. This country databook contains high-level insights into Argentina branded generics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account